checkAd

     145  0 Kommentare MaxLinear, Inc. Announces First Quarter 2024 Financial Results

    MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced financial results for the first quarter ended March 31, 2024.

    First Quarter Financial Highlights

    GAAP basis:

    • Net revenue was $95.3 million, down 24% sequentially and down 62% year-over-year.
    • GAAP gross margin was 51.7%, compared to 54.7% in the prior quarter, and 56.5% in the year-ago quarter.
    • GAAP operating expenses were $123.9 million in the first quarter 2024, or 130% of net revenue, compared to $110.3 million in the prior quarter, or 88% of net revenue, and $113.0 million in the year-ago quarter, or 45% of net revenue.
    • GAAP loss from operations was 78% of net revenue, compared to loss from operations of 33% of net revenue in the prior quarter, and income from operations of 11% of net revenue in the year-ago quarter.
    • Net cash flow provided by operating activities was $16.0 million, compared to net cash flow used in operating activities of $16.6 million in the prior quarter, and net cash flow provided by operating activities of $42.2 million in the year-ago quarter.
    • GAAP diluted loss per share was $0.88, compared to diluted loss per share of $0.47 in the prior quarter, and diluted earnings per share of $0.12 in the year-ago quarter.

    Non-GAAP basis:

    • Non-GAAP gross margin was 60.6%. This compares to 61.4% in the prior quarter, and 60.3% in the year-ago quarter.
    • Non-GAAP operating expenses were $74.8 million, or 78% of net revenue, compared to $75.7 million or 60% of net revenue in the prior quarter, and $80.8 million or 33% of net revenue in the year-ago quarter.
    • Non-GAAP loss from operations was 18% of net revenue, compared to income of 1% in the prior quarter, and income of 28% in the year-ago quarter.
    • Non-GAAP diluted loss per share was $0.21, compared to earnings of $0.01 in the prior quarter, and earnings of $0.74 in the year-ago quarter.

    Management Commentary

    “It is both gratifying and exciting to see years of product development and business execution begin to culminate in our next stage of growth as a data infrastructure company. Across our portfolio, we have the right solutions in production today to meet high-value market trends and open up significant revenue growth potential in optical datacenter and wireless network infrastructure, enterprise ethernet and storage accelerators, Wi-Fi connectivity, and fiber broadband access gateways. We believe our revenue has bottomed and is now poised for sequential growth throughout 2024. Additionally, we have continued to exercise strong fiscal discipline which we expect to deliver positive cash flow and favorable financial leverage as our growth from these investments accelerates,” commented Kishore Seendripu, Ph.D., Chairman and CEO.

    Second Quarter 2024 Business Outlook

    The company expects net revenue in the second quarter of 2024 to be approximately $90 million to $110 million. The Company also estimates the following:

    • GAAP gross margin of approximately 52.5% to 56.5%;
    • Non-GAAP gross margin of approximately 58.5% to 61.5%;
    • GAAP operating expenses of approximately $103 million to $113 million;
    • Non-GAAP operating expenses of approximately $72 million to $78 million;
    • GAAP and non-GAAP interest and other expense of approximately $0.5 million to $1 million each; and
    • GAAP and non-GAAP diluted share count of approximately 83.5 million each.

    Webcast and Conference Call

    MaxLinear will host its first quarter financial results conference call today, April 24, 2024 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-407-3109 / International: 1-201-493-6798. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at https://investors.maxlinear.com, and will be archived and available after the call at https://investors.maxlinear.com until May 8, 2024. A replay of the conference call will also be available until May 8, 2024 by dialing US toll free: 1-877-660-6853 / International: 1-201-612-7415 and Conference ID#: 13745701.

    Cautionary Note Concerning Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including our current guidance for second quarter 2024 net revenue, and GAAP and non-GAAP amounts for each of the following: gross margins, operating expenses, interest and other expenses, and diluted share counts); our potential growth and revenue opportunities; market trends; settlement of bonus awards for our 2024 performance period; and statements by our Chairman and CEO. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation; risks relating to our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers’ expected demand for certain of our products; the geopolitical and economic tensions among the countries in which we conduct business; increased tariffs, export controls or imposition of other trade barriers; our ability to obtain or retain government authorization to export certain of our products or technology; risks related to the loss of, or a significant reduction in orders from major customers; costs of legal proceedings; information technology failures; a decrease in the average selling prices of our products; substantial quarterly and annual fluctuations in our operating results; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused by undetected defects or bugs in our products; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; risks related to security vulnerabilities of our products; use of open source software in our products; and failure to manage our relationships with, or negative impacts from, third parties.

    In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our Current Reports on Form 8-K, as well as the information to be set forth under the caption "Risk Factors" in MaxLinear's Quarterly Report on Form 10-Q for the three months ended March 31, 2024. All forward-looking statements are based on the estimates, projections and assumptions of management as of April 24, 2024, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

    Use of Non-GAAP Financial Measures

    To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating expenses as a percentage of net revenue, non-GAAP income (loss) from operations as percentage of revenue, non-GAAP interest and other expenses, non-GAAP diluted earnings (loss) per share, and non-GAAP diluted share count. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance-based bonus plan for 2024, which we currently intend to settle in shares of our common stock; (iii) accruals related to our performance-based bonus plan for 2023, which we settled in shares of common stock in February 2024; (iv) amortization of purchased intangible assets; (v) research and development funded by others; (vi) acquisition and integration costs related to our acquisitions, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion; (vii) impairment of intangible assets; (viii) severance and other restructuring charges; (ix) other non-recurring interest and other income (expenses), net attributable to acquisitions; and (x) non-cash income tax benefits and expenses. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP financial measures. Non-GAAP financial measures are subject to limitations, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.

    We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that we believe are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.

    The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:

    Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.

    Performance-based equity consists of accruals related to our executive and non-executive bonus programs, and have been excluded from our non-GAAP net income for all periods reported. Bonus payments for the 2023 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in February 2024. We currently expect that bonus awards under our fiscal 2024 program will be settled in common stock in the first quarter of fiscal 2025.

    Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, acquisition and integration costs primarily consisting of professional and consulting fees, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion; ticking fees paid to lenders following the termination of such merger which were recorded in other expense; and accretion of discount on contingent consideration to interest expense.

    Research and development funded by others represents proceeds received under contracts for jointly funded R&D projects to develop technology that may be commercialized into a product in the future. Initially such proceeds may not yet be recognized in GAAP results if, pursuant to contract terms, the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions. Once such conditions have been resolved, the proceeds are recognized in GAAP results, and accordingly, reversed from non-GAAP results.

    Impairment losses are related to abandonment of acquired or purchased intangible assets.

    Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities.

    Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.

    Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, we are also unable to predict their probable significance, particularly related to stock-based compensation and its related tax effects as well as potential impairments, a quantitative reconciliation is not available without unreasonable efforts and accordingly, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, we have not provided a reconciliation for non-GAAP guidance provided for the second quarter 2024.

    About MaxLinear, Inc.

    MaxLinear, Inc. (Nasdaq:MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.

    MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.

    MAXLINEAR, INC.

    UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except per share data)

     

     

    Three Months Ended

     

    March 31, 2024

     

    December 31, 2023

     

    March 31, 2023

    Net revenue

    $

    95,269

     

     

    $

    125,353

     

     

    $

    248,442

     

    Cost of net revenue

     

    46,001

     

     

     

    56,814

     

     

     

    108,135

     

    Gross profit

     

    49,268

     

     

     

    68,539

     

     

     

    140,307

     

    Operating expenses:

     

     

     

     

     

    Research and development

     

    64,766

     

     

     

    65,250

     

     

     

    67,291

     

    Selling, general and administrative

     

    36,488

     

     

     

    34,384

     

     

     

    38,653

     

    Impairment losses

     

     

     

     

     

     

     

    2,438

     

    Restructuring charges

     

    22,630

     

     

     

    10,648

     

     

     

    4,648

     

    Total operating expenses

     

    123,884

     

     

     

    110,282

     

     

     

    113,030

     

    Income (loss) from operations

     

    (74,616

    )

     

     

    (41,743

    )

     

     

    27,277

     

    Interest income

     

    1,822

     

     

     

    1,781

     

     

     

    633

     

    Interest expense

     

    (2,711

    )

     

     

    (2,909

    )

     

     

    (2,487

    )

    Other income (expense), net

     

    1,434

     

     

     

    240

     

     

     

    (324

    )

    Total other income (expense), net

     

    545

     

     

     

    (888

    )

     

     

    (2,178

    )

    Income (loss) before income taxes

     

    (74,071

    )

     

     

    (42,631

    )

     

     

    25,099

     

    Income tax provision (benefit)

     

    (1,762

    )

     

     

    (4,131

    )

     

     

    15,566

     

    Net income (loss)

    $

    (72,309

    )

     

    $

    (38,500

    )

     

    $

    9,533

     

    Net income (loss) per share:

     

     

     

     

     

    Basic

    $

    (0.88

    )

     

    $

    (0.47

    )

     

    $

    0.12

     

    Diluted

    $

    (0.88

    )

     

    $

    (0.47

    )

     

    $

    0.12

     

    Shares used to compute net income (loss) per share:

     

     

     

     

     

    Basic

     

    82,349

     

     

     

    81,681

     

     

     

    79,471

     

    Diluted

     

    82,349

     

     

     

    81,681

     

     

     

    81,338

     

     

    MAXLINEAR, INC.

    UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)

     

    Three Months Ended

     

    March 31, 2024

     

    December 31, 2023

     

    March 31, 2023

    Operating Activities

     

     

     

     

     

    Net income (loss)

    $

    (72,309

    )

     

    $

    (38,500

    )

     

    $

    9,533

     

    Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

     

     

     

     

     

    Amortization and depreciation

     

    16,684

     

     

     

    16,593

     

     

     

    19,202

     

    Impairment losses

     

     

     

     

     

     

     

    2,438

     

    Amortization of debt issuance costs and accretion of discount on debt and leases

     

    688

     

     

     

    703

     

     

     

    548

     

    Stock-based compensation

     

    17,061

     

     

     

    16,413

     

     

     

    16,448

     

    Deferred income taxes

     

    (2,685

    )

     

     

    (10,954

    )

     

     

    8,128

     

    Loss on disposal of property and equipment

     

    390

     

     

     

     

     

     

    40

     

    Gain on sale of investments

     

     

     

     

    (434

    )

     

     

     

    Unrealized holding gain on investments

     

     

     

     

    (2,152

    )

     

     

    (152

    )

    Impairment of leased right-of-use assets

     

    2,038

     

     

     

     

     

     

     

    (Gain) loss on extinguishment of lease liabilities

     

    (569

    )

     

     

     

     

     

     

    (Gain) loss on foreign currency and other

     

    (968

    )

     

     

    2,335

     

     

     

    362

     

    Excess tax (benefits) deficiencies on stock based awards

     

    1,367

     

     

     

    276

     

     

     

    (507

    )

    Changes in operating assets and liabilities:

     

     

     

     

     

    Accounts receivable, net

     

    44,389

     

     

     

    (12,363

    )

     

     

    (16,931

    )

    Inventory

     

    3,783

     

     

     

    15,034

     

     

     

    10,959

     

    Prepaid expenses and other assets

     

    (2,044

    )

     

     

    887

     

     

     

    (4,338

    )

    Accounts payable, accrued expenses and other current liabilities

     

    9,275

     

     

     

    (11,514

    )

     

     

    (886

    )

    Accrued compensation

     

    8,707

     

     

     

    932

     

     

     

    7,210

     

    Accrued price protection liability

     

    (6,451

    )

     

     

    3,474

     

     

     

    (9,877

    )

    Lease liabilities

     

    (2,505

    )

     

     

    (2,780

    )

     

     

    (3,095

    )

    Other long-term liabilities

     

    (881

    )

     

     

    5,477

     

     

     

    3,077

     

    Net cash provided by (used in) operating activities

     

    15,970

     

     

     

    (16,573

    )

     

     

    42,159

     

    Investing Activities

     

     

     

     

     

    Purchases of property and equipment

     

    (8,342

    )

     

     

    (1,274

    )

     

     

    (5,216

    )

    Purchases of intangible assets

     

    (368

    )

     

     

    (157

    )

     

     

    (630

    )

    Cash used in acquisitions, net of cash acquired

     

     

     

     

    (940

    )

     

     

    (9,665

    )

    Sales of trading securities

     

     

     

     

    17,198

     

     

     

     

    Net cash provided by (used in) investing activities

     

    (8,710

    )

     

     

    14,827

     

     

     

    (15,511

    )

    Financing Activities

     

     

     

     

     

    Net proceeds from issuance of common stock

     

     

     

     

    1,391

     

     

     

    3

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

    (2,103

    )

     

     

    (220

    )

     

     

    (6,173

    )

    Net cash provided by (used in) financing activities

     

    (2,103

    )

     

     

    1,171

     

     

     

    (6,170

    )

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

     

    (583

    )

     

     

    779

     

     

     

    1

     

    Increase in cash, cash equivalents and restricted cash

     

    4,574

     

     

     

    204

     

     

     

    20,479

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    188,356

     

     

     

    188,152

     

     

     

    188,357

     

    Cash, cash equivalents and restricted cash at end of period

    $

    192,930

     

     

    $

    188,356

     

     

    $

    208,836

     

     

     

     

     

     

     

    MAXLINEAR, INC.

    UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS

    (in thousands)

     

     

    March 31, 2024

     

    December 31, 2023

     

    March 31, 2023

    Assets

     

     

     

     

     

    Current assets:

     

     

     

     

     

    Cash and cash equivalents

    $

    191,882

     

    $

    187,288

     

    $

    207,850

    Short-term restricted cash

     

    1,028

     

     

    1,051

     

     

    964

    Short-term investments

     

     

     

     

     

    18,681

    Accounts receivable, net

     

    126,230

     

     

    170,619

     

     

    188,733

    Inventory

     

    96,125

     

     

    99,908

     

     

    149,585

    Prepaid expenses and other current assets

     

    29,414

     

     

    29,159

     

     

    27,773

    Total current assets

     

    444,679

     

     

    488,025

     

     

    593,586

    Long-term restricted cash

     

    20

     

     

    17

     

     

    22

    Property and equipment, net

     

    68,338

     

     

    66,431

     

     

    77,691

    Leased right-of-use assets

     

    27,468

     

     

    31,264

     

     

    26,357

    Intangible assets, net

     

    64,939

     

     

    73,630

     

     

    96,352

    Goodwill

     

    318,588

     

     

    318,588

     

     

    318,910

    Deferred tax assets

     

    72,176

     

     

    69,493

     

     

    57,515

    Other long-term assets

     

    34,417

     

     

    32,809

     

     

    28,045

    Total assets

    $

    1,030,625

     

    $

    1,080,257

     

    $

    1,198,478

     

     

     

     

     

     

    Liabilities and stockholders’ equity

     

     

     

     

     

    Current liabilities

    $

    223,854

     

    $

    222,129

     

    $

    300,162

    Long-term lease liabilities

     

    23,897

     

     

    26,243

     

     

    21,239

    Long-term debt

     

    122,529

     

     

    122,375

     

     

    121,910

    Other long-term liabilities

     

    22,362

     

     

    23,245

     

     

    21,055

    Stockholders’ equity

     

    637,983

     

     

    686,265

     

     

    734,112

    Total liabilities and stockholders’ equity

    $

    1,030,625

     

    $

    1,080,257

     

    $

    1,198,478

     

    MAXLINEAR, INC.

    UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

    (in thousands, except per share data)

     

     

    Three Months Ended

     

    March 31, 2024

     

    December 31, 2023

     

    March 31, 2023

    GAAP gross profit

    $

    49,268

     

     

    $

    68,539

     

     

    $

    140,307

     

    Stock-based compensation

     

    181

     

     

     

    137

     

     

     

    210

     

    Performance based equity

     

    72

     

     

     

    17

     

     

     

    91

     

    Amortization of purchased intangible assets

     

    8,221

     

     

     

    8,332

     

     

     

    9,321

     

    Non-GAAP gross profit

     

    57,742

     

     

     

    77,025

     

     

     

    149,929

     

     

     

     

     

     

     

    GAAP R&D expenses

     

    64,766

     

     

     

    65,250

     

     

     

    67,291

     

    Stock-based compensation

     

    (10,441

    )

     

     

    (11,061

    )

     

     

    (11,455

    )

    Performance based equity

     

    (4,929

    )

     

     

    (1,918

    )

     

     

    (3,635

    )

    Research and development funded by others

     

    (1,000

    )

     

     

    (2,000

    )

     

     

    (1,000

    )

    Non-GAAP R&D expenses

     

    48,396

     

     

     

    50,271

     

     

     

    51,201

     

     

     

     

     

     

     

    GAAP SG&A expenses

     

    36,488

     

     

     

    34,384

     

     

     

    38,653

     

    Stock-based compensation

     

    (6,439

    )

     

     

    (5,215

    )

     

     

    (4,784

    )

    Performance based equity

     

    (2,427

    )

     

     

    (1,324

    )

     

     

    (1,744

    )

    Amortization of purchased intangible assets

     

    (591

    )

     

     

    (591

    )

     

     

    (928

    )

    Acquisition and integration costs

     

    (664

    )

     

     

    (1,799

    )

     

     

    (1,601

    )

    Non-GAAP SG&A expenses

     

    26,367

     

     

     

    25,455

     

     

     

    29,596

     

     

     

     

     

     

     

    GAAP impairment losses

     

     

     

     

     

     

     

    2,438

     

    Impairment losses

     

     

     

     

     

     

     

    (2,438

    )

    Non-GAAP impairment losses

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP restructuring expenses

     

    22,630

     

     

     

    10,648

     

     

     

    4,648

     

    Restructuring charges

     

    (22,630

    )

     

     

    (10,648

    )

     

     

    (4,648

    )

    Non-GAAP restructuring expenses

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP income (loss) from operations

     

    (74,616

    )

     

     

    (41,743

    )

     

     

    27,277

     

    Total non-GAAP adjustments

     

    57,595

     

     

     

    43,042

     

     

     

    41,855

     

    Non-GAAP income (loss) from operations

     

    (17,021

    )

     

     

    1,299

     

     

     

    69,132

     

     

     

     

     

     

     

    GAAP interest and other income (expense), net

     

    545

     

     

     

    (888

    )

     

     

    (2,178

    )

    Non-recurring interest and other income (expense), net

     

    73

     

     

     

    54

     

     

     

    111

     

    Non-GAAP interest and other income (expense), net

     

    618

     

     

     

    (834

    )

     

     

    (2,067

    )

     

     

     

     

     

     

    GAAP income (loss) before income taxes

     

    (74,071

    )

     

     

    (42,631

    )

     

     

    25,099

     

    Total non-GAAP adjustments

     

    57,668

     

     

     

    43,096

     

     

     

    41,966

     

    Non-GAAP income (loss) before income taxes

     

    (16,403

    )

     

     

    465

     

     

     

    67,065

     

     

     

     

     

     

     

    GAAP income tax provision (benefit)

     

    (1,762

    )

     

     

    (4,131

    )

     

     

    15,566

     

    Adjustment for non-cash tax benefits/expenses

     

    2,762

     

     

     

    4,177

     

     

     

    (8,859

    )

    Non-GAAP income tax provision

     

    1,000

     

     

     

    46

     

     

     

    6,707

     

     

     

     

     

     

     

    GAAP net income (loss)

     

    (72,309

    )

     

     

    (38,500

    )

     

     

    9,533

     

    Total non-GAAP adjustments before income taxes

     

    57,668

     

     

     

    43,096

     

     

     

    41,966

     

    Less: total tax adjustments

     

    2,762

     

     

     

    4,177

     

     

     

    (8,859

    )

    Non-GAAP net income (loss)

    $

    (17,403

    )

     

    $

    419

     

     

    $

    60,358

     

     

     

     

     

     

     

    Shares used in computing non-GAAP basic net income per share

     

    82,349

     

     

     

    81,681

     

     

     

    79,471

     

    Shares used in computing non-GAAP diluted net income per share

     

    82,349

     

     

     

    82,681

     

     

     

    81,338

     

    Non-GAAP basic net income (loss) per share

    $

    (0.21

    )

     

    $

    0.01

     

     

    $

    0.76

     

    Non-GAAP diluted net income (loss) per share

    $

    (0.21

    )

     

    $

    0.01

     

     

    $

    0.74

     

     

    MAXLINEAR, INC.

    UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
    AS A PERCENTAGE OF NET REVENUE

     

     

    Three Months Ended

     

    March 31, 2024

     

    December 31, 2023

     

    March 31, 2023

    GAAP gross margin

    51.7

    %

     

    54.7

    %

     

    56.5

    %

    Stock-based compensation

    0.2

    %

     

    0.1

    %

     

    0.1

    %

    Performance based equity

    0.1

    %

     

    %

     

    %

    Amortization of purchased intangible assets

    8.6

    %

     

    6.7

    %

     

    3.8

    %

    Non-GAAP gross margin

    60.6

    %

     

    61.4

    %

     

    60.3

    %

     

     

     

     

     

     

    GAAP R&D expenses

    68.0

    %

     

    52.1

    %

     

    27.1

    %

    Stock-based compensation

    (11.0

    )%

     

    (8.8

    )%

     

    (4.6

    )%

    Performance based equity

    (5.2

    )%

     

    (1.5

    )%

     

    (1.5

    )%

    Research and development funded by others

    (1.1

    )%

     

    (1.6

    )%

     

    (0.4

    )%

    Non-GAAP R&D expenses

    50.8

    %

     

    40.1

    %

     

    20.6

    %

     

     

     

     

     

     

    GAAP SG&A expenses

    38.3

    %

     

    27.4

    %

     

    15.6

    %

    Stock-based compensation

    (6.8

    )%

     

    (4.2

    )%

     

    (1.9

    )%

    Performance based equity

    (2.6

    )%

     

    (1.1

    )%

     

    (0.7

    )%

    Amortization of purchased intangible assets

    (0.6

    )%

     

    (0.5

    )%

     

    (0.4

    )%

    Acquisition and integration costs

    (0.7

    )%

     

    (1.4

    )%

     

    (0.6

    )%

    Non-GAAP SG&A expenses

    27.7

    %

     

    20.3

    %

     

    11.9

    %

     

     

     

     

     

     

    GAAP impairment losses

    %

     

    %

     

    1.0

    %

    Impairment losses

    %

     

    %

     

    (1.0

    )%

    Non-GAAP impairment losses

    %

     

    %

     

    %

     

     

     

     

     

     

    GAAP restructuring expenses

    23.8

    %

     

    8.5

    %

     

    1.9

    %

    Restructuring charges

    (23.8

    )%

     

    (8.5

    )%

     

    (1.9

    )%

    Non-GAAP restructuring expenses

    %

     

    %

     

    %

     

     

     

     

     

     

    GAAP income (loss) from operations

    (78.3

    )%

     

    (33.3

    )%

     

    11.0

    %

    Total non-GAAP adjustments

    60.5

    %

     

    34.3

    %

     

    16.9

    %

    Non-GAAP income (loss) from operations

    (17.9

    )%

     

    1.0

    %

     

    27.7

    %

     

     

     

     

     

     

    GAAP interest and other income (expense), net

    0.6

    %

     

    (0.7

    )%

     

    (0.9

    )%

    Non-recurring interest and other income (expense), net

    0.1

    %

     

    %

     

    %

    Non-GAAP interest and other income (expense), net

    0.7

    %

     

    (0.7

    )%

     

    (0.8

    )%

     

     

     

     

     

     

    GAAP income (loss) before income taxes

    (77.8

    )%

     

    (34.0

    )%

     

    10.1

    %

    Total non-GAAP adjustments before income taxes

    60.5

    %

     

    34.4

    %

     

    16.9

    %

    Non-GAAP income (loss) before income taxes

    (17.2

    )%

     

    0.4

    %

     

    27.0

    %

     

     

     

     

     

     

    GAAP income tax provision (benefit)

    (1.9

    )%

     

    (3.3

    )%

     

    6.3

    %

    Adjustment for non-cash tax benefits/expenses

    2.9

    %

     

    3.3

    %

     

    (3.6

    )%

    Non-GAAP income tax provision

    1.1

    %

     

    %

     

    2.7

    %

     

     

     

     

     

     

    GAAP net income (loss)

    (75.9

    )%

     

    (30.7

    )%

     

    3.8

    %

    Total non-GAAP adjustments before income taxes

    60.5

    %

     

    34.4

    %

     

    16.9

    %

    Less: total tax adjustments

    2.9

    %

     

    3.3

    %

     

    (3.6

    )%

    Non-GAAP net income (loss)

    (18.3

    )%

     

    0.3

    %

     

    24.3

    %

     


    The MaxLinear Stock at the time of publication of the news with a raise of +0,53 % to 20,89EUR on Nasdaq stock exchange (24. April 2024, 21:55 Uhr).

    Diskutieren Sie über die enthaltenen Werte

    Aktuelle Themen


    Business Wire (engl.)
    0 Follower
    Autor folgen

    MaxLinear, Inc. Announces First Quarter 2024 Financial Results MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced financial results for the first quarter ended March 31, 2024. First Quarter Financial Highlights GAAP …